Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation
Journal of Cardiovascular Electrophysiology · 2026-11 · 37 (11) · 2740-2750
DOI: 10.1111/jce.70519 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 06.10.2026. Verfasst von Michel Abou Khalil und 17 weiteren Autor:innen. Beteiligte Einrichtung: Tulane Research Innovation for Arrhythmia Discovery, Tulane University School of Medicine, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Pulmonary Veins, Atrial Fibrillation, Catheter Ablation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary vein isolation (PVI) is the standard ablation strategy for paroxysmal atrial fibrillation (PAF). Despite guideline recommendations favoring PVI alone in PAF, some operators routinely perform extra pulmonary vein ablation (PVI+) during initial procedures.
Objective
To determine frequency of PVI+ strategy for treatment of PAF in the real world and examine its impact on arrhythmic recurrence and progression compared to PVI alone.
Methods
Using the TriNetX research network, we identified adults with PAF who underwent catheter ablation between January 2020 and January 2024. Recurrence was defined as repeat ablation, cardioversion, or antiarrhythmic drug (AAD) use beyond a 3‐month blanking period. Progression to persistent AF and atypical atrial flutter were also assessed. Kaplan‐Meier analysis was performed with 3‐year follow‐up.
Results
Before matching, 5134 of 18,891 patients (27.2%) underwent PVI+. In the propensity matched analysis ( n = 5020 per group), recurrence was significantly higher in the PVI+ group (HR 1.28, 95% CI 1.16–1.42; p < 0.001). Repeat ablation, cardioversion and AAD use were more common with PVI+ (HR 1.99, 95% CI 1.60–2.46; p < 0.0001, HR 1.37, 95% CI 1.13–1.66; p = 0.001, and HR 1.41, 95% CI 1.05–1.87; p = 0.020, respectively). Progression to persistent AF was higher with PVI+ (HR 1.37, 95% CI 1.23–1.53, p < 0.001), as was atypical atrial flutter (HR 2.63, 95% CI 1.97–3.50; p < 0.0001).
Conclusion
Extra‐pulmonary vein ablation during first‐time PAF ablation remains common in real‐world practice but is associated with worse outcomes including repeat ablation, cardioversion, AAD use, atrial flutter, and progression to persistent AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tulane Research Innovation for Arrhythmia Discovery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
ORCID-Profile: Michel Abou Khalil, Christian M Massad, Eli Tsakiris, Maximilian Moersdorf, Mohammad Montaser Atasi, Alex El Darzi, Carlo El Khoury, Ghassan Bidaoui, Hadi Younes, Amitabh Pandey, Han Feng, Nassir F Marrouche, Omar Kreidieh
Zitieren
APA
Khalil, M. A., Massad, C. M., Tsakiris, E., Herbst, W., Moersdorf, M., Atasi, M. M., Menassa, Y., Darzi, A. E., Khoury, C. E., Bidaoui, G., Younes, H., Jia, Y., Montiel, R., Pandey, A., Feng, H., Marashly, Q., Marrouche, N. F., & Kreidieh, O. (2026). Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 37(11), 2740-2750. https://doi.org/10.1111/jce.70519
Vancouver
Khalil MA, Massad CM, Tsakiris E, Herbst W, Moersdorf M, Atasi MM, et al. Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2026;37(11):2740-2750. doi:10.1111/jce.70519
BibTeX
@article{Khalil2026,
author = {Khalil, Michel Abou and Massad, Christian M and Tsakiris, Eli and Herbst, William and Moersdorf, Maximilian and Atasi, Mohammad Montaser and Menassa, Yara and Darzi, Alex El and Khoury, Carlo El and Bidaoui, Ghassan and Younes, Hadi and Jia, Yishi and Montiel, Rodolfo and Pandey, Amitabh and Feng, Han and Marashly, Qussay and Marrouche, Nassir F and Kreidieh, Omar},
title = {Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {11},
pages = {2740--2750},
doi = {10.1111/jce.70519}
}
EUVIMED